Reduce Costs. Improve Patient Outcomes. Improve Star Ratings.

Samford University's Center for Healthcare Innovation and Patient Outcomes Research (CHIPOR) provides meaningful analysis to assist hospitals, health systems and other health care organizations improve patient outcomes while reducing costs and improving star ratings. 

The center conducts innovative, interdisciplinary research and analysis on a variety of pharmacotherapeutic issues. Based in Samford's McWhorter School of Pharmacy, the center draws from broad expertise across the health sciences, business and other disciplines. We provide an unbiased evaluation of existing data sets and seek out opportunities to evaluate the following: 

  • Patient safety and quality of care
  • Models to improve medication adherence 
  • Process improvement and systems intervention
  • Health professions practice and research
  • Health/pharmacoeconomic research


Healthcare costs in the United States are increasing at an alarming rate. According to the Kaiser Family Foundation, the gross domestic product (GDP) for healthcare increased from 7.2 percent in 1970 to 17.9 percent in 2009/2010. The United States spent $2.6 trillion in healthcare in 2010, which amounts to approximately $8,402 per person. This increase may be due predominantly to new technologies, including prescription drug products, used to treat these disease states. Prescription drug costs only accounts for 10 percent of healthcare expenditures, however, prescription drug expenditures increased 114 percent from 2000 to 2010.

The current healthcare model that is used in the United States is unsustainable. As a result, policy makers and others are trying to determine a better way to deliver the most appropriate care efficiently. Although the Affordable Care Act was implemented to gain better efficiencies in the healthcare system, important challenges remain that prohibit the rapid reduction of health-care related GDP to a sustainable amount.

In addition to these challenges, medication misadventures continue to have a deleterious effect on patient health. Drug-related injuries are associated with $3.5 billion excess per year. In addition, morbidity and mortality associated with medication adventures is estimated to be $77 billion per year.

Mission and Vision


We evaluate models of care and develop innovative solutions that improve the health of patients.


To be a recognized leader for improving health through innovative research.

Key Services+

Some of CHIPORs research activities include, but are not limited to the following:

Hospital and health system support

Evaluating data points surrounding medication spend rates, improving metrics for pharmacy-related CMS Stars Ratings, and designing patient outcomes-related research

Traditional drug information services

Drug monograph preparation, policy and procedure development, newsletter development, antibiogram development

Community pharmacy support

Assist in identifying patients for targeted interventions and provision of MTM interventions

*Please note that CHIPOR provides support for outcomes-related research only. We are unable to provide statistical expertise to aid in research projects.

Hours & Staff


Monday - Friday: 8:00 a.m. - 4:30 p.m. during normal University operating hours


Maisha Kelly Freeman, Pharm.D., MS, BCPS, FASCP

Professor and Director, Center for Healthcare Innovation and Patient Outcomes Research

Georges Adunlin, Ph.D.

Assistant professor

Sandra Boyken

Manager, Center for Healthcare Innovation and Patient Outcomes Research


The Center for Healthcare Innovation and Patient Outcomes Research website (the Site) functions as a resource for pharmacy students and faculty and is maintained by faculty and staff at Samford University.

Neither Samford University nor its trustees, employees, volunteers or affiliates (“Samford”) is dispensing medical advice or pharmacy consultation services through CHIPOR. The information provided throughout the Site is not intended to be a replacement for appropriate medical and/or pharmacy care. Any information regarding drug usage, medical interpretation, and/or drug literature analysis strictly represents the opinions of the faculty and staff providing such information.

Users of the Site do so at their own risk. While faculty and staff make every effort to ensure the accuracy and timeliness of the information contained on the Site, there is no guaranty that the information provided is accurate, current or applicable to any specific individual. Accordingly, Samford shall not be responsible for the continued currency of the information, discrepancies, or errors appearing on the Site and shall in no event be liable for injuries (including death) to any party which may occur as a result of reliance upon any materials provided on the Site, the misinterpretation thereof or adverse drug reactions that may occur.

CHIPOR funding is provided by the McWhorter School of Pharmacy, Samford University, and contractual clients. There are no known conflicts of interest associated with CHIPOR receiving funding from these sources.

Advertising via the Site is prohibited and no visitor tracking mechanisms are utilized.

The Site may include links to third-party web sites; however, Samford does not endorse the content of such websites. Samford is not responsible for the content of linked third-party sites, or third-party advertisements, and does not make any representations regarding their content or accuracy. Use of third-party websites is at the user’s own risk and subject to the terms and conditions of use for such sites. Samford does not endorse any product, service, or treatment appearing on the Site.